Aspirin reduces risk of preeclampsia, premature delivery, and adverse pregnancy outcomes
S
Aspirin modestly reduces the risk of preeclampsia, premature delivery, and serious adverse pregnancy outcomes in at-risk women, according to a meta-analysis published online May 17 in the Lancet.
Lisa M. Askie, PhD, from the University of Sydney in Australia, and colleagues performed a meta-analysis of 31 randomized clinical trials of antiplatelet agents to prevent preeclampsia. The trials involved 32,217 women and 32,819 infants, and 98% of women were in trials of 50 to 150 mg of aspirin alone per day.
The researchers found that women receiving antiplatelet agents had a reduced risk of preeclampsia (RR, 0.90), a reduced risk of delivering before 34 weeks (RR, 0.90), and a reduced risk of having a serious adverse outcome (RR, 0.90). Antiplatelet agents did not significantly affect the risk of death in fetus or infant, having a small-for-gestational-age infant, or bleeding in the women or their infants.
Askie LM, Duley L, Henderson-Smart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369:1791-1798.
Single iron infusion in late pregnancy significantly reduces anemia risk
January 22nd 2025A recent study found that a single dose of intravenous iron in the third trimester is superior to oral iron in reducing anemia rates in pregnant women, ensuring better outcomes for mother and baby.
Read More
Study highlights need for interventions to prevent postpartum smoking relapse
January 21st 2025Smoking cessation during pregnancy not only reduces pregnancy complications but also lowers the risk of relapse and new smoking initiation in the first postpartum year, according to a recent study.
Read More
